Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-059996
Date:2021-10-05
Issuer: NGM BIOPHARMACEUTICALS INC (NGM)
Original Submission Date:

Reporting Person:

LIEU HSIAO D
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-10-05 M 2,000 a $12.06 2,000 direct
COMMON STOCK 2021-10-05 S 2,000 d $22.00 0 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 12.06 2021-10-05 deemed execution date M 2,000 (d) 2029-03-18 common stock 2,000 $12.06 190,000 direct
Footnotes
IDfootnote
f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on august 24, 2021.
f2 the shares subject to the stock option vest over a four-year period measured from the grant date, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
WhaleWisdom Logo

Elevate your investments